Literature DB >> 5195839

Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.

H Tiitinen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5195839

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


× No keyword cloud information.
  17 in total

1.  Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids.

Authors:  B Auclair; D E Nix; R D Adam; G T James; C A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

3.  Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.

Authors:  Z Desta; N V Soukhova; D A Flockhart
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 4.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.

Authors:  T Zysset; E Peretti
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Simplified method for determining acetylator phenotype.

Authors:  H Schröder
Journal:  Br Med J       Date:  1972-08-26

7.  Simple method for determining isoniazid acetylator phenotype.

Authors:  D W Russell
Journal:  Br Med J       Date:  1970-08-08

8.  Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.

Authors:  A K Karim; M S Elfellah; D A Evans
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

Review 9.  Variability in drug metabolism: importance of genetic constitution.

Authors:  J H Schellens; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

Review 10.  Clinically significant drug interactions with antituberculosis agents.

Authors:  J M Grange; P A Winstanley; P D Davies
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.